Iron Path Capital-backed VION Biosciences completed the acquisition of Ansh Labs.

Iron Path Capital-backed VION Biosciences, a life science platform company, completed the acquisition of Ansh Labs, a biotechnology company. Financial terms were not disclosed. "The momentum our team has this year to expand into underserved markets has been tremendous, and it is proof that the diagnostic market is growing and requires the right innovations needed to move science forward. Ansh’s commitment to innovation and quality is a natural fit for VION, and our acquisition of Ansh Labs coupled with our two previous acquisitions collectively give VION the combined resources, capabilities, core competencies, and of course the talents of all VION’s employees to meet the goals of our customers now and into the future," Mark Thornton, VION Biosciences CEO.